You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Jul 30, 2026
Sale
Calculated transaction value
$89.95K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Jul 30, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$23.58
Jul 30, 2026
First close after public filing
$23.21
Jul 31, 2026
30-day return after filing
+11.07%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,847 shares @ $23.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000012
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$89.95K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX Current | Sale | Jul 30, 2026 | $89.95K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jul 30, 2026 | $0 |